ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0264

Joint Acoustic Emissions as a Biomarker to Differentiate Between Active and Inactive Juvenile Idiopathic Arthritis via 2-stage Machine Learning Classifier

Luis Rosa1, Sevda Gharehbaghi1, Omer Inan1, Daniel Whittingslow2, Lori Ponder3 and Sampath Prahalad4, 1Georgia Institute of Technology, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Children's Healthcare of Atlanta, Atlanta, GA, 4Emory + Children's Pediatric Institute, Atlanta, GA

Meeting: ACR Convergence 2021

Keywords: Juvenile idiopathic arthritis, Knee, machine learning

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most prevalent chronic rheumatic disease and can result in disability in children. JIA most commonly affects the knee. Despite the widespread occurrence of JIA, its heterogeneous presentation and lack of reliable biomarkers make diagnosis and quantifying treatment response challenging. If untreated, the synovitis in JIA can lead to cartilage degeneration and even bone erosion. To evaluate knee health status non-invasively, we can use contact accelerometers that capture the vibrations generated by internal friction of articulating surfaces during movement, also known as joint acoustic emissions (JAE). In this study, we used JAEs to evaluate children’s knees and distinguish between healthy, inactive JIA, and active JIA.

Methods: We collected knee JAEs from 51 participants while performing flexion/extensions, including 34 subjects with JIA (23 active/11 inactive) and 17 healthy controls. To these JAE signals, we applied filtering and denoising techniques to extract 15 time-frequency audio features to be used as training data for our Logistic Regression machine learning (ML) classification model. This classifier was implemented in two stages, where at each we obtained a knee health score that indicates the predicted class. The first stage distinguished between healthy and JIA subjects with active and inactive JIA grouped together. The second stage then took only the subjects identified as JIA and classified them as either active or inactive. Hence, our 2-stage classifier was used to evaluate not only presence of, but also severity of JIA.

Results: We validated our 2-stage classifier through leave-one-subject-out cross-validation and obtained an overall 3-class accuracy of 76% when differentiating between healthy, inactive JIA, and active JIA subjects. We obtained a Stage 1 accuracy of 78% and a Stage 2 accuracy of 81%. The least accurate class was inactive JIA, which had both the lower number of sample subjects for training (11) and has the most uncertain label since designation of knee arthritis as “inactive” is primarily clinical and thus is subject to variability. Notice error compounding from both stages results in a lower overall accuracy since second stage depends on first stage predictions, hence, with further ML optimization, we see potential for improved diagnostic accuracy.

Conclusion: These results support the use of JAEs as a novel non-invasive digital biomarker for knee joint health assessment. More accurate characterization of synovitis by magnetic resonance imaging can facilitate improved accuracy of our training dataset which in turn could allow us to differentiate between different levels of synovial inflammation. We have shown that close collaboration between clinicians and bioengineers can result in personalized assessment and thereby improving management of arthritis in children.


Disclosures: L. Rosa, None; S. Gharehbaghi, None; O. Inan, None; D. Whittingslow, None; L. Ponder, None; S. Prahalad, Novartis, 1.

To cite this abstract in AMA style:

Rosa L, Gharehbaghi S, Inan O, Whittingslow D, Ponder L, Prahalad S. Joint Acoustic Emissions as a Biomarker to Differentiate Between Active and Inactive Juvenile Idiopathic Arthritis via 2-stage Machine Learning Classifier [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/joint-acoustic-emissions-as-a-biomarker-to-differentiate-between-active-and-inactive-juvenile-idiopathic-arthritis-via-2-stage-machine-learning-classifier/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-acoustic-emissions-as-a-biomarker-to-differentiate-between-active-and-inactive-juvenile-idiopathic-arthritis-via-2-stage-machine-learning-classifier/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology